Recurrences can occur in up to 30% of surgically managed patients with localized renal cell carcinoma. Existing uro-oncological guidelines differ in recommendations of surveillance protocols and identification of patients at risk. A recent study shows that the existence of differing guidelines results in inadequate harms, cancer control and costs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA Cancer J. Clin. 66, 7–30 (2016).
Janzen, N. K., Kim, H. L., Figlin, R. A. & Belldegrun, A. S. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol. Clin. North Am. 30, 843–852 (2003).
Sun, M. et al. Treatment management of small renal masses in the 21st century: a paradigm shift. Ann. Surg. Oncol. 19, 2380–2387 (2012).
Lobo, J., Nelson, M., Nandanan, N. & Krupski, T. Comparison of renal cell carcinoma surveillance guidelines: competing tradeoffs. J. Urol. http://dx.doi.org/10.1016/j.juro.2015.12.094 (2016)
Donat, S. M. et al. Follow-up for clinically localized renal neoplasms: AUA guideline. J. Urol. 190, 407–416 (2013).
Kassouf, W. et al. Follow-up guidelines after radical or partial nephrectomy for localized and locally advanced renal cell carcinoma. Can. Urol. Assoc. J. 3, 73–76 (2009).
Ljungberg, B. et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur. Urol. 67, 913–924 (2015).
Motzer, R. J. et al. Kidney cancer, version 3.2015. J. Natl Compr. Canc. Netw. 13, 151–159 (2015).
Holden, W. L., Juhaeri, J. & Dai, W. Benefit-risk analysis: a proposal using quantitative methods. Pharmacoepidemiol. Drug Saf. 12, 611–616 (2003).
Schutz, F. A. et al. Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study. Lancet Oncol. 14, 81–87 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Sun, M., Choueiri, T. Recurrence in renal cell carcinoma: the work is not done. Nat Rev Urol 13, 246–247 (2016). https://doi.org/10.1038/nrurol.2016.57
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2016.57